Julie Rathbun | Communications, Investor Relations |
Jonathan Drachman | CEO |
Priti Patel | CMO |
Sean Smith | Vice President, Finance |
Mary Kate | Bank of America |
Joe Catanzaro | Piper Sandler |
Charles Zhu | Guggenheim |
Mara Goldstein | Mizuho |
Good afternoon and thank you for joining us today for Neoleukin Therapeutics Conference Call. At this time, all participants are in listen-only mode.
Following the conclusion of the prepared remarks, we will conduct a question-and-answer session, and instructions will follow at that time.
As a reminder, today’s conference call is being recorded. I would now like to turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics.